Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,75 USD | +1,16% | -0,57% | +19,05% |
13/03 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
13/03 | Spero Therapeutics, Inc. rapporteert winstresultaten voor het vierde kwartaal eindigend op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 46
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Treatments for Multi-drug Resistant Bacterial Infections
100,0
%
| 54 | 100,0 % | 104 | 100,0 % | +93,95% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 54 | 100,0 % | 104 | 100,0 % | +93,95% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Satyavrat Shukla
CEO | Chief Executive Officer | 52 | 04-01-21 |
Ankit Mahadevia
FOU | Founder | 43 | 01-04-13 |
Esther Rajavelu
DFI | Director of Finance/CFO | 46 | 06/11 |
Kamal Hamed
CTO | Chief Tech/Sci/R&D Officer | 63 | 15-09-22 |
Angela Talley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Timothy Keutzer
COO | Chief Operating Officer | 56 | - |
Ted Jenkins
IRC | Investor Relations Contact | - | - |
James P. Brady
HRO | Human Resources Officer | - | - |
Ian A. Critchley
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Frank Thomas
BRD | Director/Board Member | 54 | 01-07-17 |
John Pottage
BRD | Director/Board Member | 71 | 14-08-18 |
Scott Jackson
BRD | Director/Board Member | 59 | 16-04-20 |
Milind Deshpande
FOU | Founder | 68 | 01-01-14 |
Director/Board Member | 61 | 01-09-15 | |
Ankit Mahadevia
FOU | Founder | 43 | 01-04-13 |
Cynthia Smith
BRD | Director/Board Member | 55 | 19-03-19 |
Director/Board Member | 53 | 11-10-21 | |
Satyavrat Shukla
CEO | Chief Executive Officer | 52 | 04-01-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 53 869 139 | 42 904 616 ( 79,65 %) | 0 | 79,65 % |
Bedrijfsgegevens
Spero Therapeutics, Inc.
675 Massachusetts Avenue 14th floor
02139, Cambridge
+857 242 1600
http://www.sperotherapeutics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,05% | 94,27 mln. | |
+2,56% | 108 mld. | |
+10,02% | 104 mld. | |
+6,87% | 23,66 mld. | |
-11,91% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,98% | 18,2 mld. | |
-14,02% | 16,19 mld. | |
+4,61% | 13,72 mld. | |
+35,05% | 12,22 mld. |
- Beurs
- Aandelen
- Aandeel Spero Therapeutics, Inc. - Nasdaq
- Onderneming Spero Therapeutics, Inc.